We started by testing two fluorescent syngeneic models of leukemia to study circulation kinetics, a BCR-ABL driven B cell ALL model and an MLL-AF9 driven AML model31–36, each paired with healthy recipients. The gene discussed is KMT2A; the disease is acute myeloid leukemia.